Concepedia

Parames Thavasu

PT

Statistics

Publications

6

Citations

316

H-Index

6

Active since

1999

Affiliations

Institute of Cancer Research(Current)

Cancer Research UK

Churchill Hospital

Royal Marsden NHS Foundation Trust

Parames Thavasu is an author at Institute of Cancer Research specializing in oncology, molecular oncology, and pharmacology.

Publications per year

1999–2017

6

Publications

6

Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma.

David Propper, David Chao, Jeremy Braybrooke et al. · PubMed · 2003 · 115 citations

, , +17

The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer

Craig P. Carden, Adam Stewart, Parames Thavasu et al. · Molecular Cancer Therapeutics · 2012 · 97 citations

, , +17

The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients.

Parames Thavasu, David Propper, Alexander McDonald et al. · PubMed · 1999 · 51 citations

, , +14

Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models

Anne-Christine Wong Te Fong, Parames Thavasu, Sladjana Gagrica et al. · Oncotarget · 2017 · 26 citations · Full text

, , +17

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments

Anna Minchom, Parames Thavasu, Zai Ahmad et al. · PLoS ONE · 2017 · 16 citations · Full text

, , +17

1–5 of 6